Ursodeoxycholic acid in chronic hepatitis C
AUTOR(ES)
Poupon, Raoul
FONTE
BMJ Group
RESUMO
Cytoprotective but anti‐apoptotic
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2095696Documentos Relacionados
- A large‐scale, multicentre, double‐blind trial of ursodeoxycholic acid in patients with chronic hepatitis C
- Antifibrotic therapy in chronic hepatitis C
- Cardiac Disorder in Chronic Hepatitis C
- Seroprevalence of hepatitis E virus in chronic hepatitis C in Brazil
- Ursodeoxycholic acid dissolution of gallstones in cystic fibrosis